Inkjet Printing of Drug-Loaded Mesoporous Silica Nanoparticles—A Platform for Drug Development
AbstractMesoporous silica nanoparticles (MSNs) have shown great potential in improving drug delivery of poorly water soluble (BCS class II, IV) and poorly permeable (BCS class III, IV) drugs, as well as facilitating successful delivery of unstable compounds. The nanoparticle technology would allow improved treatment by reducing adverse reactions of currently approved drugs and possibly reintroducing previously discarded compounds from the drug development pipeline. This study aims to highlight important aspects in mesoporous silica nanoparticle (MSN) ink formulation development for digital inkjet printing technology and to advice on choosing a method (2D/3D) for nanoparticle print deposit characterization. The results show that both unfunctionalized and polyethyeleneimine (PEI) surface functionalized MSNs, as well as drug-free and drug-loaded MSN–PEI suspensions, can be successfully inkjet-printed. Furthermore, the model BCS class IV drug remained incorporated in the MSNs and the suspension remained physically stable during the processing time and steps. This proof-of-concept study suggests that inkjet printing technology would be a flexible deposition method of pharmaceutical MSN suspensions to generate patterns according to predefined designs. The concept could be utilized as a versatile drug screening platform in the future due to the possibility of accurately depositing controlled volumes of MSN suspensions on various materials. View Full-Text
- Supplementary File 1:
PDF-Document (PDF, 1750 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Wickström, H.; Hilgert, E.; Nyman, J.O.; Desai, D.; Şen Karaman, D.; de Beer, T.; Sandler, N.; Rosenholm, J.M. Inkjet Printing of Drug-Loaded Mesoporous Silica Nanoparticles—A Platform for Drug Development. Molecules 2017, 22, 2020.
Wickström H, Hilgert E, Nyman JO, Desai D, Şen Karaman D, de Beer T, Sandler N, Rosenholm JM. Inkjet Printing of Drug-Loaded Mesoporous Silica Nanoparticles—A Platform for Drug Development. Molecules. 2017; 22(11):2020.Chicago/Turabian Style
Wickström, Henrika; Hilgert, Ellen; Nyman, Johan O.; Desai, Diti; Şen Karaman, Didem; de Beer, Thomas; Sandler, Niklas; Rosenholm, Jessica M. 2017. "Inkjet Printing of Drug-Loaded Mesoporous Silica Nanoparticles—A Platform for Drug Development." Molecules 22, no. 11: 2020.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.